Beam weights are out today (Apache 2.0 license).
We integrated Beam across 40+ different partners.
And are also open sourcing Mirror CLI - the harness Beam was trained against.
Happy building.
Beam is now available across platforms, with open weights under the Apache 2.0 license - in collaboration with an ecosystem of 40+ partners.
We're releasing:
- Weights, tokenizer, and reference implementation
- BF16, FP8 and NVFP4 weights and a DFlash2 drafter
- The open source harness we built and trained Beam on: Mirror CLI
Weights and model card on Hugging Face: https://t.co/tPqWpk9RXL
Introducing Beam: a highly efficient agentic open model with 501B total parameters and 23B active.
- Frontier reasoning efficiency
- Advances the Western open frontier on coding & agentic tasks
- Trained end-to-end from scratch
Full weights release this month.
Learn more about Beam: https://t.co/c3Qx2cpM8G
In these days of anxiety, I wanted to find a way to continue to share some of the music that gives me comfort. The first of my #SongsOfComfort: Dvořák – "Going Home”
Stay safe.
We are going to take this support and transform it into genomic-based therapies for our patients with Lysosomal Storage Diseases!! So honored and humbled to be the recipient of such amazing generosity!
https://t.co/OgvVkqjTNI
Any #biology#postdoc with prior experience in the #CRISPR field interested in an exciting career opportunity in #raredisease and development of therapies? Check out our job listing here:
https://t.co/BZhlbfP6Xz
I am grateful to be at @chocchildrens, which supports our vibrant #BattenDisease / #CLN program!
For more information, check these links:
https://t.co/M7Umyx1gDo
https://t.co/EwHtz9rmXH
Special thanks to @Team4TitusEly for their advocacy and prayers: https://t.co/nxsmTZLAo7
Do you know someone diagnosed with #BattenCLN7 or #BattenCLN5 ? Looking for families fighting these diseases for clinical trial work in early stages, please let me know if we aren’t already in touch! Let’s stop these killers once and for all! #raredisease#battenhope
This is a fantastic step forward for people who have #CLN2#batten disease. A possibility with gene therapy of a longer term (possibly permanent?) treatment!
https://t.co/foMi7WS4r5
Congrats to Drs. Schulz, Emily, and all the #CLN2#brineura investigators for publishing the hope-bringing results of this #Battens clinical trial https://t.co/0hGS67f0g7